Fresenius Medical Care AG & Co. KGaA (FMS) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	19.4B	19.6B	19.3B	19.5B	19.4B
Cost of Revenue	14.3B	14.6B	14.6B	14.5B	14.5B
Gross Profit	5.1B	5.0B	4.8B	4.9B	4.9B
Operating Expenses
R&D Expense	154.3M	158.0M	183.5M	232.0M	228.6M
SG&A Expense	3.0B	3.0B	3.1B	3.2B	3.2B
General & Admin Expense	2.6B	2.4B	2.5B	2.5B	2.4B
Selling & Marketing Expense	390.9M	618.1M	660.4M	706.4M	800.9M
Other Expenses	98.6M	11.4M	(37.0M)	127.3M	(17.1M)
Total Operating Expenses	3.2B	3.2B	3.3B	3.6B	3.4B
Cost and Expenses	17.5B	17.8B	17.9B	18.1B	17.9B
Operating Income (EBIT)	1.9B	1.8B	1.5B	1.4B	1.5B
Non-Operating
Interest Income	62.1M	69.6M	71.6M	88.2M	67.7M
Interest Expense	383.0M	384.4M	407.0M	424.6M	360.1M
Net Interest Income	(320.9M)	(314.8M)	(335.5M)	(336.4M)	(292.5M)
Other Non-Op Income/Expense	(390.6M)	(314.6M)	(410.5M)	(336.4M)	(292.5M)
Non-Operating Income (excl Interest)	22.3M	(69.8M)	3.4M	(88.2M)	(67.7M)
EBT (Pre-Tax Income)	1.5B	1.5B	1.1B	1.0B	1.2B
Income Tax Expense	314.3M	321.0M	316.1M	300.6M	325.0M
Bottom Line
Net Income	937.8M	978.4M	537.9M	499.0M	673.4M
Earnings from Cont. Ops	1.2B	1.2B	740.9M	732.5M	894.3M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	937.8M	978.4M	537.9M	499.0M	673.4M
Per Share
Basic EPS	$1.67	$1.68	$0.92	$0.85	$0.57
Diluted EPS	$1.67	$1.68	$0.92	$0.85	$0.57
Revenue Per Share	$36.03	$33.70	$32.95	$33.15	$16.54
Shares
Basic Shares Outstanding	539.2M	582.4M	586.8M	586.8M	1.2B
Diluted Shares Outstanding	539.2M	582.4M	586.8M	586.8M	1.2B
Profitability Metrics
EBITDA	3.4B	3.4B	3.2B	3.2B	3.4B
D&A	1.6B	1.5B	1.7B	1.8B	1.8B
EBIT	1.9B	1.9B	1.5B	1.5B	1.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026